NCT05545462

Brief Summary

it is the study for the disease called umbilical granuloma to look for the better treatment option which can be performed by healthcare physicians and local nurses and even parents

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 19, 2022

Completed
Last Updated

September 19, 2022

Status Verified

September 1, 2022

Enrollment Period

12 months

First QC Date

September 12, 2022

Last Update Submit

September 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison Of Doxycycline And Common Salt (TableCooking) For Treatment Of Umbilical Granuloma In Children: A Randomised Control Trial

    for the treatment of Umbilical Granuloma multiple treatment options are available. and we have studied about the two methods the common salt any doxycycline The use of common salt to treat umbilical granuloma is a simple, highly effective, and inexpensive with minimum complications or relapse as compared to doxycycline. Treatment can be performed by physicians, nurses, primary health-care staff in remote areas, and even by parents.

    1 year

Study Arms (2)

COMPARISON OF DOXYCYCLINE AND COMMON SALT FOR TREATMENT OF UMBILICAL GRANULOMA IN CHILDREN

EXPERIMENTAL

to study the comparison of doxycycline and common salt for the treatment of umbilical granuloma to check which is more effective safe timesaving and can be performed by even parents it showed that common salt is more effective than doxycycline

Drug: Doxycyclin

COMPARISON BETWEEN COMMON SALT AND SOXYCYLIN FOR TREATMENT OF UMBILICAL GRANULOMA

EXPERIMENTAL

to study the comparison of doxycycline and common salt for the treatment of umbilical granuloma to check which is more effective safe timesaving and can be performed by even parents it showed that common salt is more effective than doxycycline

Other: COMMON SALT

Interventions

THE USE OF DOXYCYCLIN POWDER IN THE TREATMENT OF UMBILICAL GRANULOMA

Also known as: COMMON SALT
COMPARISON OF DOXYCYCLINE AND COMMON SALT FOR TREATMENT OF UMBILICAL GRANULOMA IN CHILDREN

THE USE OF COMMON SALT IN TREATMENT OF UMBILICAL GRANULOMA

COMPARISON BETWEEN COMMON SALT AND SOXYCYLIN FOR TREATMENT OF UMBILICAL GRANULOMA

Eligibility Criteria

Age1 Month - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Neonates and infants (age\<1yr)
  • Both genders
  • Confirmed by ultrasonography and sinography (if applicable)

You may not qualify if:

  • \. If any treatment is already given 2. Patient lost in follow up 3. Refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pakistan institute of medical Sciences/ Shaheed Zulfiqar Ali Bhutto Medical University

Islamabad, Pakistan

Location

MeSH Terms

Interventions

DoxycyclineSodium Chloride

Intervention Hierarchy (Ancestors)

TetracyclinesNaphthacenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPolycyclic CompoundsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Muhammad Awais

Study Record Dates

First Submitted

September 12, 2022

First Posted

September 19, 2022

Study Start

October 1, 2020

Primary Completion

September 30, 2021

Study Completion

September 30, 2021

Last Updated

September 19, 2022

Record last verified: 2022-09

Locations